$LITE · Lumentum Holdings Inc.
Lumentum Holdings Inc. entered into a definitive merger agreement with Marvell Technology, Inc. on November 1, 2026, under which Marvell will acquire Lumentum in an all-stock transaction. Each Lumentum common share converts into 4.500 Marvell shares, with Series A Preferred holders able to elect Marvell Series B Preferred instead. The deal includes a $5.8B Marvell termination fee, a $2.9B Lumentum termination fee, and a $3.2B regulatory termination fee, with an outside date of November 1, 2027 (extendable to August 1, 2028 for regulatory delays).
- Marvell will acquire Lumentum in an all-stock merger at a fixed exchange ratio of 4.500 Marvell shares per Lumentum share.
- Lumentum's board unanimously approved the deal and recommended stockholders adopt the Merger Agreement.
- Marvell must pay a $5.8B termination fee if its board withdraws its recommendation or accepts a superior proposal.
- Lumentum faces a reciprocal $2.9B termination fee; a $3.2B regulatory termination fee applies if antitrust approvals fail.
- Three Lumentum directors will join Marvell's board post-closing; CEO Michael Hurlston received a 280G tax reimbursement agreement.
LITE dropped 8.57% to $840.70 in the regular session following the announcement, suggesting the market views the fixed exchange ratio as unfavorable to Lumentum shareholders or is pricing in regulatory risk given the $3.2B regulatory termination fee.
A $5.8B termination fee — among the largest ever in tech M&A — signals both the strategic importance of this deal and the substantial antitrust risk that could block it.
This is a major semiconductor/photonics consolidation, pairing Lumentum's optical components with Marvell's data infrastructure silicon. The deal structure — all-stock with a fixed ratio — mirrors recent large-cap tech M&A but the $5.8B/$2.9B breakup fees are unusually large, underscoring the strategic stakes.
The deal requires HSR and other regulatory approvals; a $3.2B regulatory termination fee is payable if antitrust clearance fails. The outside date extends to August 1, 2028, signaling a potentially prolonged review. The fixed exchange ratio exposes Lumentum shareholders to Marvell share price declines before closing.